United States Restriction Endonucleases Market Report 2016

October 2016 | 116 pages | ID: U56359AE3A1EN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Restriction Endonucleases

Revenue, means the sales value of Restriction Endonucleases

This report studies sales (consumption) of Restriction Endonucleases in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

• Thermo Fisher Scientific, Inc. (U.S.)
• Merck KGaA (Germany)
• New England Biolabs, Inc. (U.S.)
• Promega (U.S.)
• Illumina, Inc. (U.S.)
• Agilent Technologies, Inc. (U.S.)
• F. Hoffmann-la Roche Ltd. (Switzerland)
• Takara Bio Inc. (Japan)
• QIAGEN N.V. (The Netherlands)
• Becton, Dickinson and Company (U.S.)

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Type I
• Type II
• Type III

Split by applications, this report focuses on sales, market share and growth rate of Restriction Endonucleases in each application, can be divided into

• PCR
• Sequencing
• Cloning

Contents

United States Restriction Endonucleases Market Report 2016

1 RESTRICTION ENDONUCLEASES OVERVIEW

1.1 Product Overview and Scope of Restriction Endonucleases
1.2 Classification of Restriction Endonucleases
  1.2.1 Type I
  1.2.2 Type II
  1.2.3 Type III
1.3 Application of Restriction Endonucleases
  1.3.1 PCR
  1.3.2 Sequencing
  1.3.3 Cloning
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Restriction Endonucleases (2011-2021)
  1.4.1 United States Restriction Endonucleases Sales and Growth Rate (2011-2021)
  1.4.2 United States Restriction Endonucleases Revenue and Growth Rate (2011-2021)

2 UNITED STATES RESTRICTION ENDONUCLEASES COMPETITION BY MANUFACTURERS

2.1 United States Restriction Endonucleases Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Restriction Endonucleases Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Restriction Endonucleases Average Price by Manufactures (2015 and 2016)
2.4 Restriction Endonucleases Market Competitive Situation and Trends
  2.4.1 Restriction Endonucleases Market Concentration Rate
  2.4.2 Restriction Endonucleases Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 UNITED STATES RESTRICTION ENDONUCLEASES SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2011-2016)

3.1 United States Restriction Endonucleases Sales and Market Share by Type (2011-2016)
3.2 United States Restriction Endonucleases Revenue and Market Share by Type (2011-2016)
3.3 United States Restriction Endonucleases Price by Type (2011-2016)
3.4 United States Restriction Endonucleases Sales Growth Rate by Type (2011-2016)

4 UNITED STATES RESTRICTION ENDONUCLEASES SALES (VOLUME) BY APPLICATION (2011-2016)

4.1 United States Restriction Endonucleases Sales and Market Share by Application (2011-2016)
4.2 United States Restriction Endonucleases Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities

5 UNITED STATES RESTRICTION ENDONUCLEASES MANUFACTURERS PROFILES/ANALYSIS

5.1 Thermo Fisher Scientific, Inc. (U.S.)
  5.1.1 Company Basic Information, Manufacturing Base and Competitors
  5.1.2 Restriction Endonucleases Product Type, Application and Specification
    5.1.2.1 Type I
    5.1.2.2 Type II
  5.1.3 Thermo Fisher Scientific, Inc. (U.S.) Restriction Endonucleases Sales, Revenue, Price and Gross Margin (2011-2016)
  5.1.4 Main Business/Business Overview
5.2 Merck KGaA (Germany)
  5.2.2 Restriction Endonucleases Product Type, Application and Specification
    5.2.2.1 Type I
    5.2.2.2 Type II
  5.2.3 Merck KGaA (Germany) Restriction Endonucleases Sales, Revenue, Price and Gross Margin (2011-2016)
  5.2.4 Main Business/Business Overview
5.3 New England Biolabs, Inc. (U.S.)
  5.3.2 Restriction Endonucleases Product Type, Application and Specification
    5.3.2.1 Type I
    5.3.2.2 Type II
  5.3.3 New England Biolabs, Inc. (U.S.) Restriction Endonucleases Sales, Revenue, Price and Gross Margin (2011-2016)
  5.3.4 Main Business/Business Overview
5.4 Promega (U.S.)
  5.4.2 Restriction Endonucleases Product Type, Application and Specification
    5.4.2.1 Type I
    5.4.2.2 Type II
  5.4.3 Promega (U.S.) Restriction Endonucleases Sales, Revenue, Price and Gross Margin (2011-2016)
  5.4.4 Main Business/Business Overview
5.5 Illumina, Inc. (U.S.)
  5.5.2 Restriction Endonucleases Product Type, Application and Specification
    5.5.2.1 Type I
    5.5.2.2 Type II
  5.5.3 Illumina, Inc. (U.S.) Restriction Endonucleases Sales, Revenue, Price and Gross Margin (2011-2016)
  5.5.4 Main Business/Business Overview
5.6 Agilent Technologies, Inc. (U.S.)
  5.6.2 Restriction Endonucleases Product Type, Application and Specification
    5.6.2.1 Type I
    5.6.2.2 Type II
  5.6.3 Agilent Technologies, Inc. (U.S.) Restriction Endonucleases Sales, Revenue, Price and Gross Margin (2011-2016)
  5.6.4 Main Business/Business Overview
5.7 F. Hoffmann-la Roche Ltd. (Switzerland)
  5.7.2 Restriction Endonucleases Product Type, Application and Specification
    5.7.2.1 Type I
    5.7.2.2 Type II
  5.7.3 F. Hoffmann-la Roche Ltd. (Switzerland) Restriction Endonucleases Sales, Revenue, Price and Gross Margin (2011-2016)
  5.7.4 Main Business/Business Overview
5.8 Takara Bio Inc. (Japan)
  5.8.2 Restriction Endonucleases Product Type, Application and Specification
    5.8.2.1 Type I
    5.8.2.2 Type II
  5.8.3 Takara Bio Inc. (Japan) Restriction Endonucleases Sales, Revenue, Price and Gross Margin (2011-2016)
  5.8.4 Main Business/Business Overview
5.9 QIAGEN N.V. (The Netherlands)
  5.9.2 Restriction Endonucleases Product Type, Application and Specification
    5.9.2.1 Type I
    5.9.2.2 Type II
  5.9.3 QIAGEN N.V. (The Netherlands) Restriction Endonucleases Sales, Revenue, Price and Gross Margin (2011-2016)
  5.9.4 Main Business/Business Overview
5.10 Becton, Dickinson and Company (U.S.)
  5.10.2 Restriction Endonucleases Product Type, Application and Specification
    5.10.2.1 Type I
    5.10.2.2 Type II
  5.10.3 Becton, Dickinson and Company (U.S.) Restriction Endonucleases Sales, Revenue, Price and Gross Margin (2011-2016)
  5.10.4 Main Business/Business Overview

6 RESTRICTION ENDONUCLEASES MANUFACTURING COST ANALYSIS

6.1 Restriction Endonucleases Key Raw Materials Analysis
  6.1.1 Key Raw Materials
  6.1.2 Price Trend of Key Raw Materials
  6.1.3 Key Suppliers of Raw Materials
  6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
  6.2.1 Raw Materials
  6.2.2 Labor Cost
  6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Restriction Endonucleases

7 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

7.1 Restriction Endonucleases Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Restriction Endonucleases Major Manufacturers in 2015
7.4 Downstream Buyers

8 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

8.1 Marketing Channel
  8.1.1 Direct Marketing
  8.1.2 Indirect Marketing
  8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
  8.2.1 Pricing Strategy
  8.2.2 Brand Strategy
  8.2.3 Target Client
8.3 Distributors/Traders List

9 MARKET EFFECT FACTORS ANALYSIS

9.1 Technology Progress/Risk
  9.1.1 Substitutes Threat
  9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change

10 UNITED STATES RESTRICTION ENDONUCLEASES MARKET FORECAST (2016-2021)

10.1 United States Restriction Endonucleases Sales, Revenue Forecast (2016-2021)
10.2 United States Restriction Endonucleases Sales Forecast by Type (2016-2021)
10.3 United States Restriction Endonucleases Sales Forecast by Application (2016-2021)
10.4 Restriction Endonucleases Price Forecast (2016-2021)

11 RESEARCH FINDINGS AND CONCLUSION

12 APPENDIX

Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Restriction Endonucleases
Table Classification of Restriction Endonucleases
Figure United States Sales Market Share of Restriction Endonucleases by Type in 2015
Table Application of Restriction Endonucleases
Figure United States Sales Market Share of Restriction Endonucleases by Application in 2015
Figure PCR Examples
Figure Sequencing Examples
Figure Cloning Examples
Figure United States Restriction Endonucleases Sales and Growth Rate (2011-2021)
Figure United States Restriction Endonucleases Revenue and Growth Rate (2011-2021)
Table United States Restriction Endonucleases Sales of Key Manufacturers (2015 and 2016)
Table United States Restriction Endonucleases Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Restriction Endonucleases Sales Share by Manufacturers
Figure 2016 Restriction Endonucleases Sales Share by Manufacturers
Table United States Restriction Endonucleases Revenue by Manufacturers (2015 and 2016)
Table United States Restriction Endonucleases Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Restriction Endonucleases Revenue Share by Manufacturers
Table 2016 United States Restriction Endonucleases Revenue Share by Manufacturers
Table United States Market Restriction Endonucleases Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Restriction Endonucleases Average Price of Key Manufacturers in 2015
Figure Restriction Endonucleases Market Share of Top 3 Manufacturers
Figure Restriction Endonucleases Market Share of Top 5 Manufacturers
Table United States Restriction Endonucleases Sales by Type (2011-2016)
Table United States Restriction Endonucleases Sales Share by Type (2011-2016)
Figure United States Restriction Endonucleases Sales Market Share by Type in 2015
Table United States Restriction Endonucleases Revenue and Market Share by Type (2011-2016)
Table United States Restriction Endonucleases Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Restriction Endonucleases by Type (2011-2016)
Table United States Restriction Endonucleases Price by Type (2011-2016)
Figure United States Restriction Endonucleases Sales Growth Rate by Type (2011-2016)
Table United States Restriction Endonucleases Sales by Application (2011-2016)
Table United States Restriction Endonucleases Sales Market Share by Application (2011-2016)
Figure United States Restriction Endonucleases Sales Market Share by Application in 2015
Table United States Restriction Endonucleases Sales Growth Rate by Application (2011-2016)
Figure United States Restriction Endonucleases Sales Growth Rate by Application (2011-2016)
Table Thermo Fisher Scientific, Inc. (U.S.) Basic Information List
Table Thermo Fisher Scientific, Inc. (U.S.) Restriction Endonucleases Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Thermo Fisher Scientific, Inc. (U.S.) Restriction Endonucleases Sales Market Share (2011-2016)
Table Merck KGaA (Germany) Basic Information List
Table Merck KGaA (Germany) Restriction Endonucleases Sales, Revenue, Price and Gross Margin (2011-2016)
Table Merck KGaA (Germany) Restriction Endonucleases Sales Market Share (2011-2016)
Table New England Biolabs, Inc. (U.S.) Basic Information List
Table New England Biolabs, Inc. (U.S.) Restriction Endonucleases Sales, Revenue, Price and Gross Margin (2011-2016)
Table New England Biolabs, Inc. (U.S.) Restriction Endonucleases Sales Market Share (2011-2016)
Table Promega (U.S.) Basic Information List
Table Promega (U.S.) Restriction Endonucleases Sales, Revenue, Price and Gross Margin (2011-2016)
Table Promega (U.S.) Restriction Endonucleases Sales Market Share (2011-2016)
Table Illumina, Inc. (U.S.) Basic Information List
Table Illumina, Inc. (U.S.) Restriction Endonucleases Sales, Revenue, Price and Gross Margin (2011-2016)
Table Illumina, Inc. (U.S.) Restriction Endonucleases Sales Market Share (2011-2016)
Table Agilent Technologies, Inc. (U.S.) Basic Information List
Table Agilent Technologies, Inc. (U.S.) Restriction Endonucleases Sales, Revenue, Price and Gross Margin (2011-2016)
Table Agilent Technologies, Inc. (U.S.) Restriction Endonucleases Sales Market Share (2011-2016)
Table F. Hoffmann-la Roche Ltd. (Switzerland) Basic Information List
Table F. Hoffmann-la Roche Ltd. (Switzerland) Restriction Endonucleases Sales, Revenue, Price and Gross Margin (2011-2016)
Table F. Hoffmann-la Roche Ltd. (Switzerland) Restriction Endonucleases Sales Market Share (2011-2016)
Table Takara Bio Inc. (Japan) Basic Information List
Table Takara Bio Inc. (Japan) Restriction Endonucleases Sales, Revenue, Price and Gross Margin (2011-2016)
Table Takara Bio Inc. (Japan) Restriction Endonucleases Sales Market Share (2011-2016)
Table QIAGEN N.V. (The Netherlands) Basic Information List
Table QIAGEN N.V. (The Netherlands) Restriction Endonucleases Sales, Revenue, Price and Gross Margin (2011-2016)
Table QIAGEN N.V. (The Netherlands) Restriction Endonucleases Sales Market Share (2011-2016)
Table Becton, Dickinson and Company (U.S.) Basic Information List
Table Becton, Dickinson and Company (U.S.) Restriction Endonucleases Sales, Revenue, Price and Gross Margin (2011-2016)
Table Becton, Dickinson and Company (U.S.) Restriction Endonucleases Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Restriction Endonucleases
Figure Manufacturing Process Analysis of Restriction Endonucleases
Figure Restriction Endonucleases Industrial Chain Analysis
Table Raw Materials Sources of Restriction Endonucleases Major Manufacturers in 2015
Table Major Buyers of Restriction Endonucleases
Table Distributors/Traders List
Figure United States Restriction Endonucleases Production and Growth Rate Forecast (2016-2021)
Figure United States Restriction Endonucleases Revenue and Growth Rate Forecast (2016-2021)
Table United States Restriction Endonucleases Production Forecast by Type (2016-2021)
Table United States Restriction Endonucleases Consumption Forecast by Application (2016-2021)